The KCTD1 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from HEK293T cells. This heterogeneous population harbors targeted gene disruption at the KCTD1 locus, offering a loss-of-function model for studying KCTD1-dependent processes. The polyclonal format captures diverse knockout alleles, avoiding clonal artifacts.
The HEK293T host cell line is a human embryonic kidney epithelial line expressing SV40 large T antigen, which promotes high-level plasmid replication and protein expression. Known for high transfection efficiency and robust growth, HEK293T cells are widely used in molecular and cellular biology for protein interaction, signaling, and functional genomics studies.
KCTD1 functions as a substrate adaptor for the CUL3-RING E3 ubiquitin ligase complex, a multimeric assembly that includes CUL3, RBX1, and additional components. Through direct interaction with CUL3, KCTD1 facilitates the transfer of ubiquitin molecules onto specific substrate proteins, marking them for recognition and degradation by the 26S proteasome. This process regulates the abundance of key transcriptional regulators and developmental factors. Although the upstream signals modulating KCTD1 activity remain unidentified, its role in substrate recruitment is critical for maintaining proteostasis. In the knockout model, the absence of KCTD1 impairs substrate ubiquitination, leading to the stabilization and potential accumulation of downstream targets, thereby perturbing transcriptional networks controlled by the CUL3-KCTD1 axis.
Within the HEK293T background, which endogenously expresses CUL3, RBX1, and the ubiquitin-proteasome machinery, KCTD1 knockout provides a powerful genetic tool to probe adaptor-specific functions. The loss of KCTD1 disrupts normal protein turnover, potentially causing dysregulation of gene expression programs involved in cell proliferation, differentiation, and stress responses. This system avoids the complexities of ectopic overexpression and enables the direct assessment of endogenous substrate dynamics using standard biochemical approaches.
Research applications span the investigation of ubiquitin-proteasome system mechanisms, protein degradation pathways, and the molecular etiology of scalp-ear-nipple syndrome, a developmental disorder linked to KCTD1 variants. Representative assays include western blotting for target protein accumulation, ubiquitination assays to monitor ligase activity, proteasome activity measurements, transcriptional reporter assays to assess pathway output, and co-immunoprecipitation experiments with CUL3 to validate adaptor interactions. The KCTD1 Knockout HEK293T Polyclonal Cells are a versatile resource for both mechanistic studies and drug discovery efforts targeting ubiquitin-dependent pathways. For further information, please contact Ascent Research.
